$864 Million is the total value of HARVARD MANAGEMENT CO INC's 45 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 2.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GOOGL | Buy | ALPHABET INCcap stk cl a | $262,769,000 | +8.5% | 120,577 | +38.5% | 30.42% | +24.4% |
| FB | Sell | META PLATFORMS INCcl a | $183,166,000 | -33.1% | 1,135,916 | -7.7% | 21.21% | -23.3% |
| SGMS | LIGHT & WONDER INC | $125,866,000 | -20.0% | 2,678,571 | 0.0% | 14.57% | -8.3% | |
| ABCL | ABCELLERA BIOLOGICS INC | $43,719,000 | +9.2% | 4,105,095 | 0.0% | 5.06% | +25.3% | |
| EQRX INC | $24,680,000 | +13.6% | 5,262,161 | 0.0% | 2.86% | +30.2% | ||
| PCT | PURECYCLE TECHNOLOGIES INC | $18,536,000 | -7.3% | 2,498,170 | 0.0% | 2.15% | +6.4% | |
| Buy | GRAB HOLDINGS LIMITEDclass a ord | $13,586,000 | +5.3% | 5,369,919 | +45.7% | 1.57% | +20.8% | |
| RVMD | REVOLUTION MEDICINES INC | $13,066,000 | -23.6% | 670,382 | 0.0% | 1.51% | -12.3% | |
| RXRX | RECURSION PHARMACEUTICALS INcl a | $12,285,000 | +13.7% | 1,509,254 | 0.0% | 1.42% | +30.3% | |
| NVDA | Buy | NVIDIA CORPORATION | $10,061,000 | +40.1% | 66,368 | +152.2% | 1.16% | +60.7% |
| MELI KASZEK PIONEER CORPclass a ord | $9,900,000 | -3.7% | 1,000,000 | 0.0% | 1.15% | +10.4% | ||
| QRVO | Buy | QORVO INC | $9,872,000 | +69.4% | 104,669 | +122.9% | 1.14% | +94.4% |
| ASML | New | ASML HOLDING N V | $9,606,000 | – | 20,186 | +100.0% | 1.11% | – |
| RLAY | RELAY THERAPEUTICS INC | $9,064,000 | -44.0% | 541,124 | 0.0% | 1.05% | -35.8% | |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $8,771,000 | +30.5% | 107,294 | +66.5% | 1.02% | +49.7% |
| AMD | Buy | ADVANCED MICRO DEVICES INC | $8,575,000 | +43.6% | 112,137 | +105.3% | 0.99% | +64.7% |
| TXG | 10X GENOMICS INC | $8,423,000 | -40.5% | 186,143 | 0.0% | 0.98% | -31.8% | |
| LRCX | Buy | LAM RESEARCH CORP | $8,153,000 | +21.1% | 19,131 | +52.8% | 0.94% | +39.0% |
| AMAT | Buy | APPLIED MATLS INC | $8,047,000 | +20.8% | 88,443 | +75.0% | 0.93% | +38.5% |
| ADI | Buy | ANALOG DEVICES INC | $7,972,000 | +15.6% | 54,568 | +30.7% | 0.92% | +32.6% |
| INTC | Buy | INTEL CORP | $7,772,000 | +4.0% | 207,752 | +37.8% | 0.90% | +19.4% |
| KNTE | KINNATE BIOPHARMA INC | $6,280,000 | +12.0% | 498,001 | 0.0% | 0.73% | +28.4% | |
| MU | Buy | MICRON TECHNOLOGY INC | $5,944,000 | -25.7% | 107,522 | +4.7% | 0.69% | -14.7% |
| PLRX | PLIANT THERAPEUTICS INC | $4,505,000 | +14.3% | 562,379 | 0.0% | 0.52% | +31.2% | |
| NRIX | NURIX THERAPEUTICS INC | $3,988,000 | -9.6% | 314,762 | 0.0% | 0.46% | +3.8% | |
| ROCKET LAB USA INC | $3,790,000 | -52.9% | 1,000,000 | 0.0% | 0.44% | -46.0% | ||
| TENAYA THERAPEUTICS INC | $3,791,000 | -52.2% | 673,270 | 0.0% | 0.44% | -45.2% | ||
| GBIO | GENERATION BIO CO | $3,348,000 | -10.6% | 510,354 | 0.0% | 0.39% | +2.6% | |
| TANGO THERAPEUTICS INC | $3,209,000 | -40.2% | 708,385 | 0.0% | 0.37% | -31.4% | ||
| AFRM | AFFIRM HLDGS INC | $3,134,000 | -61.0% | 173,560 | 0.0% | 0.36% | -55.2% | |
| CFLT | CONFLUENT INC | $3,030,000 | -43.3% | 130,383 | 0.0% | 0.35% | -35.0% | |
| SANA | SANA BIOTECHNOLOGY INC | $3,014,000 | -22.2% | 468,749 | 0.0% | 0.35% | -10.7% | |
| SURROZEN INC | $2,431,000 | -2.3% | 826,852 | 0.0% | 0.28% | +12.0% | ||
| FULC | FULCRUM THERAPEUTICS INC | $2,012,000 | -79.3% | 410,714 | 0.0% | 0.23% | -76.2% | |
| PRAX | PRAXIS PRECISION MEDICINES I | $1,907,000 | -76.0% | 778,517 | 0.0% | 0.22% | -72.4% | |
| PCTTW | PURECYCLE TECHNOLOGIES INC*w exp 03/17/202 | $1,893,000 | -7.7% | 714,285 | 0.0% | 0.22% | +5.8% | |
| DBTX | DECIBEL THERAPEUTICS INC | $1,384,000 | +38.4% | 328,798 | 0.0% | 0.16% | +58.4% | |
| PARDES BIOSCIENCES INC | $1,228,000 | -57.5% | 400,000 | 0.0% | 0.14% | -51.4% | ||
| XILIO THERAPEUTICS INC | $1,215,000 | -58.7% | 416,059 | 0.0% | 0.14% | -52.5% | ||
| PACB | PACIFIC BIOSCIENCES CALIF IN | $1,013,000 | -51.4% | 229,144 | 0.0% | 0.12% | -44.3% | |
| VIGIL NEUROSCIENCE INC | $747,000 | -63.3% | 289,460 | 0.0% | 0.09% | -58.0% | ||
| DYN | DYNE THERAPEUTICS INC | $737,000 | -28.7% | 107,252 | 0.0% | 0.08% | -18.3% | |
| MCRB | SERES THERAPEUTICS INC | $452,000 | -51.9% | 131,847 | 0.0% | 0.05% | -45.3% | |
| GMTX | GEMINI THERAPEUTICS INC | $423,000 | +21.6% | 250,000 | 0.0% | 0.05% | +40.0% | |
| MGTA | MAGENTA THERAPEUTICS INC | $399,000 | -58.7% | 332,610 | 0.0% | 0.05% | -52.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 34 | Q3 2021 | 19.4% |
| VANGUARD TAX-MANAGED INTL FD | 34 | Q3 2021 | 14.0% |
| VANGUARD INTL EQUITY INDEX F | 34 | Q3 2021 | 12.2% |
| SPDR GOLD TRUST | 34 | Q3 2021 | 8.7% |
| ISHARES TR | 34 | Q3 2021 | 4.9% |
| META PLATFORMS INC | 29 | Q3 2023 | 37.6% |
| VANGUARD SPECIALIZED PORTFOL | 28 | Q1 2020 | 2.8% |
| MAGENTA THERAPEUTICS INC | 21 | Q2 2023 | 1.4% |
| ALPHABET INC | 19 | Q3 2023 | 30.4% |
| ISHARES TR | 19 | Q3 2021 | 4.4% |
View HARVARD MANAGEMENT CO INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NuCana plc | February 12, 2021 | 1,678,239 | 3.3% |
| ADURO BIOTECH, INC. | February 08, 2019 | 640,595 | 0.8% |
| Fortress Transportation & Infrastructure Investors LLCSold out | July 08, 2016 | 0 | 0.0% |
| Alpha Security Group CORP | February 13, 2009 | 436,300 | 5.8% |
| BLOCKBUSTER INC | February 13, 2009 | 5,567,100 | 7.7% |
| ChinaGrowth North Acquisition CORPSold out | February 13, 2009 | 0 | 0.0% |
| ChinaGrowth South Acquisition CORPSold out | February 13, 2009 | 0 | 0.0% |
| GENEVA ACQUISITION CORPSold out | February 13, 2009 | 0 | 0.0% |
| Ideation Acquisition Corp. | February 13, 2009 | 310,200 | 2.5% |
| MBF Healthcare Acquisition Corp. | February 13, 2009 | 1,220 | 0.0% |
View HARVARD MANAGEMENT CO INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View HARVARD MANAGEMENT CO INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.